Bone Biologics (BBLG) Shares Outstanding (Diluted) (2015 - 2026)
Powered by 
Analysis
Bone Biologics (BBLG) Shares Outstanding (Diluted) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | 1.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 557,787.00 |
| Mar 31, 2025 | 530,542.00 |
| Dec 31, 2024 | 252,878.00 |
| Sep 30, 2024 | 292,241.00 |
| Jun 30, 2024 | 194,741.00 |
| Mar 31, 2024 | 110,157.00 |
| Dec 31, 2023 | 43,857.00 |
| Sep 30, 2023 | 65,301.00 |
| Jun 30, 2023 | 21,813.00 |
| Mar 31, 2023 | 11,202.00 |
| Dec 31, 2022 | 7,943.00 |
| Sep 30, 2022 | 7,188.00 |
| Jun 30, 2022 | 7,188.00 |
| Mar 31, 2022 | 36,844.00 |
| Dec 31, 2021 | 36,844.00 |
| Sep 30, 2021 | 36,844.00 |
| Jun 30, 2021 | 36,844.00 |